Devyani makes strong debut, Windlas lists at discount: how latest IPOs fared
Summary
Devyani International made a strong debut as its shares opened for trading at a premium of nearly 57 percent. While Krnsaa and Exxaro saw lukewarm listings, the Windlas Biotech stock started its Dalal Street journey with a discount of 5 percent.
Four stocks entered the listed arena on Dalal Street on Monday, with Devyani International outshining others making a strong debut as its shares listed at a premium of 57 percent over the issue price. Krsnaa Diagnostics shares started trading on stock exchanges BSE and NSE at a premium of 5-7 percent.
Out of the four stocks that debuted on August 16, Windlas Biotech’s was the only one that opened at a discount to its issue price. On NSE, the stock listed at a discount of 5 percent.
Here’s how the four stocks — Devyani, Windlas, Krsnaa and Exxaro — fared at the opening:
Stock | Listing price | Issue price | Premium/discount vs issue price | ||
BSE | NSE | BSE | NSE | ||
Exxaro Tiles | 126 | 126 | 120 | 5% premium | 5% premium |
Devyani International | 141 | 140.9 | 90 | 56.67 premium | 56.56% premium |
Krsnaa Diagnostics | 1025 | 1,005.55 | 954 | 7.44% premium | 5.4% premium |
Windlas Biotech | 439 | 437 | 460 | 4.57% discount | 5% discount |
Read more on the listing of Devyani, Exxaro, Krsnaa and Windlas shares here
The IPO of Devyani International — the largest franchisee of Yum Brands in India — was subscribed 27 times in a three-day bidding process that concluded on August 6. The portion reserved for qualified institutional buyers (QIB) was subscribed 95.27 times, and that for non-institutional investors 213.06 times. The quota for retail individual investors saw a subscription of 39.51 times. (Read more on Pizza Hut operator’s IPO)
The public offer of Krsnaa Diagnostics was subscribed 8.56 times. The category meant for QIBs saw a subscription of 49.83 times, and that for non-institutional investors 116.30 times. The quota for retail investors was subscribed 42.04 times. (Read more on Krsnaa IPO)
Windlas Biotech’s IPO saw a subscription of 22 times. The category for QIBs was subscribed 24.40 times, and that for non-institutional investors 15.73 times. The portion reserved for retail investors saw a subscription of 24.27 times. (Read more on Windlas Biotech IPO)
Exxaro Tiles’ IPO was subscribed 23 times in the bidding process. The portion reserved for QIBs was subscribed 13.74 times and that for non-institutional investors 2.01 times. The quota reserved for retail investors saw a 17.64 times subscription. (Read more on Exxaro IPO)
Track our market blog for more updates
Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout
3 Mins Read
Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter